Monday 15 February 2021

Reuters Health Report: Israeli study finds 94% drop in symptomatic COVID-19 cases with Pfizer vaccine

Reuters.com Newsletter

Israeli study finds 94% drop in symptomatic COVID-19 cases with Pfizer vaccine

Israel's largest healthcare provider on Sunday reported a 94% drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer's vaccine in the country's biggest study to date.

Guinea tracks potential Ebola contacts, says can overcome new outbreak

Guinea is tracking down people who potentially came in contact with Ebola patients and will rush out vaccines to the area as soon as it can get them, after three people died of the disease, Health Minister Remy Lamah said on Monday.

UK PM Johnson wants 'cautious but irreversible' path out of COVID-19 lockdown

British Prime Minister Boris Johnson said on Monday he would plot a cautious but irreversible path out of the COVID-19 lockdown this week after the vaccination of 15 million vulnerable people.

Hungary's PM seeks renewal of special powers to fight COVID-19

Hungarian Prime Minister Viktor Orban asked parliament on Monday to extend the government's special powers to handle the COVID-19 pandemic, saying only vaccinations would enable the government to ease lockdown measures introduced last autumn.

Pan-European consortium seeks big pharma partner for COVID-19 shot

A pan-European consortium developing a COVID-19 vaccine is in talks with big pharma to support the late-stage development of its shot and ramp up manufacturing, the head of German biotech firm Leukocare told Reuters.

COVID-19 vaccines touch down in Australia, New Zealand, inoculations to start

Australia and New Zealand have received their first COVID-19 vaccine deliveries and will begin rolling out inoculations in the coming week, while populous cities of Melbourne and Auckland remained locked down following the emergence of new cases.

South Korea cuts first-quarter COVID-19 vaccination plan, restricts use of AstraZeneca shot

South Korea said on Monday it will not use AstraZeneca's coronavirus vaccine on people aged 65 and older, reversing an earlier decision, and scaled back initial vaccination targets due to delayed shipments from global vaccine-sharing scheme COVAX.

J&J's vaccine implementation study in S.Africa gets regulator nod

South Africa's drugs regulator SAHPRA said on Monday it has approved an implementation study of Johnson & Johnson's COVID-19 vaccine, clearing the way to start the country's first inoculations among health workers.

Zimbabwe receives 200,000 doses of Sinopharm COVID-19 vaccines

A plane carrying Zimbabwe's first coronavirus vaccines, 200,000 doses donated by China, arrived in the capital Harare on Monday.

Italian official says 'not wrong' to use AstraZeneca vaccine in those up to 65

Administering the AstraZeneca vaccine to those aged up to 65 would not be wrong, given the delays in supplies to Italy, the head of national medicines agency AIFA said on Monday.

Pakistan lab expects Sputnik V doses for commercial sale in a week

A Pakistani lab will soon receive Russia's Sputnik V COVID-19 vaccine for commercial sale, a company official said on Sunday, making Pakistan one of the first countries to market shots privately as it scrambles to secure supplies.

Related Videos

Netflix love story marries Nollywood and Bollywood

White tiger cubs in Pakistan likely died of COVID

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS